Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, October 14, 2025
SteriPack, a contract design and manufacturing organization (CDMO) serving pharmaceutical and medical device industries, has officially changed its trading name to Ensera. The rebranding marks an expansion of services and a strategic shift in ...
read more
Tuesday, October 14, 2025
Codis, a newly established contract development and manufacturing organization (CDMO), has entered the pharmaceutical outsourcing market with a focus on commercial-scale spray drying and amorphous solid dispersion technologies.
read more
Tuesday, October 14, 2025
Almac Group has unveiled a $48 million investment aimed at advancing eClinical technologies, highlighted by the debut of its new interoperable platform, Almac Trial Coordinator™.
read more
Tuesday, October 14, 2025
Halo Pharma appointed Laurent Malgouyres as Site Director for its facility in Mirabel, Quebec, Canada. In his new role, Malgouyres will oversee production, quality, and overall site performance.
read more
Tuesday, October 14, 2025
Quotient Sciences and Biorasi have announced a strategic partnership aimed at streamlining early phase clinical trials from Investigational New Drug (IND) applications to patient proof-of-concept (POC) milestones.
read more
Thursday, October 09, 2025
Catalent has signed a global, non-exclusive license agreement with Lisata Therapeutics, securing rights to use Lisata’s proprietary certepetide peptide and its analogs in antibody-drug conjugates (ADCs) developed on Catalent’s SMARTag® technology ...
read more
Wednesday, October 08, 2025
Symeres has appointed Gabriella Gentile as Chief Operating Officer (COO). This strategic addition to the executive team supports Symeres’ transatlantic growth ambitions, building upon its strong foundations in existing and novel modalities.
read more
Wednesday, October 08, 2025
Lonza announced the operational readiness of its new aseptic drug product filling line in Stein, Switzerland. The filling line was granted a GMP license following Swissmedic approval, strengthening Lonza’s existing capacity for liquid and lyophilized...
read more
Wednesday, October 08, 2025
Recipharm has designated its Cuxhaven, Germany facility as a Centre of Excellence for analytical services supporting advanced therapy medicinal products (ATMPs) and biologics. The site now operates 500 m² of CGMP-compliant laboratories designed to ...
read more
Wednesday, October 08, 2025
The IMA Group has announced its acquisition of Chicago Research Center (CRC), a move that expands the company’s clinical trial footprint and marks its entry into dedicated sleep research.
read more
Tuesday, October 07, 2025
OXB, a cell and gene therapy CDMO, has signed and closed an asset purchase transaction to acquire a custom-built, state-of-the-art cell and gene therapy viral vector manufacturing facility in North Carolina from RTP Operating, LLC, a subsidiary of ...
read more
Tuesday, October 07, 2025
Symbiosis Pharmaceutical Services has successfully completed qualification of its new FPD 50 Flexicon automated fill/finish line at its new commercial production facility in Stirling, Scotland.
read more
Tuesday, October 07, 2025
Piramal Pharma Solutions has introduced the PODs (Plan, Own, and Deliver) Project Execution System at its Aurora, Canada facility. The Aurora site implemented this innovative system to execute seamless deliveries to customers amidst a growing ...
read more
Tuesday, October 07, 2025
CELONIC GROUP and the Carbogen Amcis Group announced a strategic partnership to offer a fully integrated Antibody-Drug Conjugate (ADC) development and manufacturing solution. The alliance combines Celonic’s advanced biologics capabilities with ...
read more
Thursday, October 02, 2025
OmniaBio, a next generation contract development and manufacturing organization (CDMO) pioneering the manufacturing of cell and gene therapies (CGT) with robotics and artificial intelligence, and BrainChild Bio Inc, a clinical-stage biotechnology ...
read more